Blake A. Morrison, PharmD, vice president, Medical and Scientific Affairs, Multiple Myeloma Research Foundation, discusses adverse events associated with new agents to treat patients with multiple myeloma.
Blake A. Morrison, PharmD
Advertisement
Articles by Blake A. Morrison, PharmD
Advertisement
Latest Updated Articles
Blake A. Morrison on Infusion Reactions With New Agents for Multiple MyelomaPublished: February 9th 2016 | Updated:
Advertisement
Advertisement
